Medtronic Inc has launched its new cardiac resynchronization therapy-pacemaker, Viva CRT-P which includes AdaptivCRT software in India. The product received a CE mark in May 2014.
“The AdaptivCRT algorithm is unique in its ability to constantly adjust and preserve patients’ natural heart rhythms,” said Shamik Dasgupta, vice president, cardiac and vascular group, Medtronic India Private Limited. “This personalized therapy is likely to reduce the need for the patient to be frequently hospitalized and the menace of stroke which needs emergency medical attention. Both these are significant issues in India and will prove to be of great value to patients,” he added.
The company states that Viva CRT-P features diagnostics tools such as OptiVol Fluid Status Monitoring and Cardiac Compass Report which provide insight into a patient’s physiological condition. These tools identify patients at risk for re-hospitalization within 30 days of discharge.
Last updated: December 26th, 2025
